Procurement Summary
Country: Germany
Summary: Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Betamethasone and Calcipotriol in all Dosage Forms, with the Exception of Ointment...
Deadline: 27 May 2026
Posting Date: 07 Jun 2024
Other Information
Notice Type: Tender
TOT Ref.No.: 102282629
Document Ref. No.: 338873-2024
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient combination of betamethasone and calcipotriol in all dosage forms, with the exception of ointment...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with
Document Type: Contract Notice
Reference Number: TED OH Betamethasone and Calcipotriol
Contract Type: supplies
Authority Type: body-pl
Doc Title: Conclusion of a non-exclusive discount contract in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient combination of betamethasone and calcipotriol in
Documents
Tender Notice